Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...

Here is a success story that demonstrates how CSI can support your clinical trial supplies. CSI managed to compress six months of...

How CSI’s scientific insight delivered an agile sourcing model and substantial cost savings for a listed biotechnology company’s global...

Unwrap CSI's Twelve Case Studies of Christmas 2020 has been a challenging year, with product shortages, borders closing, more...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more specific to tumour or cell pathologies and increasing patient numbers. Several oncology products now have ‘blockbuster’ status where sales exceed $1 billion annually. This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster produc

Webinar: How to identify and manage risks in clinical trial supplies and comparator sourcing CSI hosted a webinar with Xtalks on Monday...

Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely...

How can you be sure that your comparator sourcing partner will provide you with the best available solution? How do you know that the...

How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets...

How CSI leveraged relationships with multiple manufacturers to urgently supply large quantities of a generic drug to a global Phase 3...